Emma J. Jones

2.9k total citations
15 papers, 311 citations indexed

About

Emma J. Jones is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Emma J. Jones has authored 15 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Organic Chemistry. Recurrent topics in Emma J. Jones's work include Protein Degradation and Inhibitors (4 papers), Click Chemistry and Applications (3 papers) and Ubiquitin and proteasome pathways (3 papers). Emma J. Jones is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Click Chemistry and Applications (3 papers) and Ubiquitin and proteasome pathways (3 papers). Emma J. Jones collaborates with scholars based in United Kingdom, United States and Germany. Emma J. Jones's co-authors include Chun‐wa Chung, Robert J. Watson, Darren J. Mitchell, Emmanuel H. Demont, Paul Bamborough, Anne‐Marie Michon, Rab K. Prinjha, Paola Grandi, Robert J. Sheppard and Angela Bridges and has published in prestigious journals such as Scientific Reports, Biological Psychiatry and Journal of Medicinal Chemistry.

In The Last Decade

Emma J. Jones

14 papers receiving 300 citations

Peers

Countries citing papers authored by Emma J. Jones

Since Specialization

Citations

This map shows the geographic impact of Emma J. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma J. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma J. Jones more than expected).

Fields of papers citing papers by Emma J. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma J. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma J. Jones. The network helps show where Emma J. Jones may publish in the future.

Co-authorship network of co-authors of Emma J. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Emma J. Jones. A scholar is included among the top collaborators of Emma J. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma J. Jones. Emma J. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Predictive value of subgenual cingulate normative connectivity to TMS treatment site for antidepressant response in routine clinical practice: a prospective, multisite cohort study 2025 ·Molecular Psychiatry ·(unknown), (unknown), William Drew, (unknown), Christopher Lin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Emma J. Jones, Daniel Z. Press, Adam P. Stern, Joshua C. Brown, Tracy Barbour, Joseph J. Taylor, Linda L. Carpenter, Shan H. Siddiqi, Michael Fox	0
2	Symptom Specific TMS Targets for Depression and Anxiety: A Randomized, Controlled Trial 2024 ·Biological Psychiatry ·Joseph J. Taylor, Jing Li, Christopher Lin, Emma J. Jones, (unknown), Claudia Becker, (unknown), William Drew, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michael A. Fox, Shan H. Siddiqi	1
3	Structure–activity studies of Streptococcus pyogenes enzyme SpyCEP reveal high affinity for CXCL8 in the SpyCEP C-terminal 2023 ·Scientific Reports ·Max Pearson, Carl Haslam, Andrew Fosberry, Emma J. Jones, Mark Reglinski, Lucy Reeves, Robert J. Edwards, (unknown), Jonathan C. Brown, Danuta E. Mossakowska, James E. Pease, Shiranee Sriskandan	1
4	Development of an intracellular quantitative assay to measure compound binding kinetics 2021 ·Cell chemical biology ·(unknown), Daniel A. Thomas, John P. Evans, Matthew Campbell, (unknown), (unknown), Laurie Gordon, Emma J. Jones, Kristin M. Riching, (unknown), (unknown), (unknown), (unknown), Peter D. Craggs	1
5	Cellular Target Engagement Approaches to Monitor Epigenetic Reader Domain Interactions 2019 ·SLAS DISCOVERY ·(unknown), (unknown), (unknown), (unknown), John P. Evans, Antonia J. Lewis, Laurie Gordon, (unknown), (unknown), (unknown), Aaron Cheng, Syandan Chakraborty, Emma J. Jones, Simon C. C. Lucas, (unknown), (unknown), Peter D. Craggs	6
6	Discovery of potent and selective Spleen Tyrosine Kinase inhibitors for the topical treatment of inflammatory skin disease 2018 ·Bioorganic & Medicinal Chemistry Letters ·Michael D. Barker, John Liddle, Francis Atkinson, David M. Wilson, Marion C. Dickson, César Ramírez-Molina, Huw D. Lewis, (unknown), D.O. Somers, Margarete Neu, Emma J. Jones, Robert J. Watson	18
7	Pharmacological disruption of the MID1/α4 interaction reduces mutant Huntingtin levels in primary neuronal cultures 2018 ·Neuroscience Letters ·Olivia Monteiro, Changwei Chen, Ryan P. Bingham, Argyrides Argyrou, (unknown), (unknown), Emma J. Jones, Angela Bridges, (unknown), Sybille Krauß, Jeremy J. Lambert, Rosamund F. Langston, Susann Schweiger, Iain Uings	8
8	Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Neil Garton, Michael D. Barker, (unknown), (unknown), (unknown), Emma J. Jones, Huw D. Lewis, John Liddle, Dave Lugo, Scott McCleary, Alex Preston, César Ramírez-Molina, Margarete Neu, (unknown), Don O. Somers, Robert J. Watson, David M. Wilson	8
9	Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: Foundations for understanding inhibitor selectivity 2015 ·Bioorganic & Medicinal Chemistry ·Adam K. Charnley, M.A. Convery, (unknown), Emma J. Jones, (unknown), Angela Bridges, Michael T. Ouellette, Rachel D. Totoritis, Benjamin Schwartz, Bryan W. King, David D. Wisnoski, James Kang, Patrick M. Eidam, Bartholomew J. Votta, Peter J. Gough, Robert W. Marquis, John Bertin, Linda Casillas	24
10	Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors 2015 ·Journal of Medicinal Chemistry ·Paul Bamborough, Chun‐wa Chung, Rebecca C. Furze, Paola Grandi, Anne‐Marie Michon, Robert J. Sheppard, Heather Barnett, Hawa Diallo, David P. Dixon, (unknown), Emma J. Jones, (unknown), Darren J. Mitchell, Rab K. Prinjha, Christina Rau, Robert J. Watson, Thilo Werner, Emmanuel H. Demont	64
11	1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain 2014 ·ACS Medicinal Chemistry Letters ·Emmanuel H. Demont, Paul Bamborough, Chun‐wa Chung, Peter D. Craggs, David J. Fallon, Laurie Gordon, Paola Grandi, Clare I. Hobbs, (unknown), Emma J. Jones, Armelle Le Gall, Anne‐Marie Michon, Darren J. Mitchell, Rab K. Prinjha, Andy D. Roberts, Robert J. Sheppard, Robert J. Watson	68
12	Enabling Lead Discovery for Histone Lysine Demethylases by High-Throughput RapidFire Mass Spectrometry 2011 ·SLAS DISCOVERY ·Sue Hutchinson, Melanie Leveridge, (unknown), Peter Francis, Laura Williams, Michelle Gee, J. A. Muñoz, (unknown), Anthony Shillings, Emma J. Jones, Paul Homes, (unknown), Chun‐wa Chung, Angela Bridges, Argyrides Argyrou	72
13	1-Aryl-3,4-dihydroisoquinoline inhibitors of JNK3 2009 ·Bioorganic & Medicinal Chemistry Letters ·J.A. Christopher, Francis Atkinson, B.D. Bax, Murray J. B. Brown, (unknown), Tsu Tshen Chuang, Emma J. Jones, J. Mosley, (unknown)	29
14	Identification, Cloning, and Expression of a Functional Phenylalanyl-tRNA Synthetase (pheRS) from Staphylococcus aureus 2001 ·Protein Expression and Purification ·(unknown), Martin Hibbs, Emma J. Jones, Lucy Mensah, Christine M. Richardson, Andrew Fosberry, (unknown), (unknown), James R. Brown, Owen Jenkins	6
15	Comparison of mesoridazine and chlordiazepoxide in psychoneurotic patients. 1969 ·PubMed ·(unknown), (unknown), (unknown), Emma J. Jones, (unknown), (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact